524661 — Welcure Drugs and Pharmaceuticals Balance Sheet
0.000.00%
- IN₹1.05bn
- IN₹2.08bn
- IN₹245.50m
- 16
- 31
- 76
- 34
Annual balance sheet for Welcure Drugs and Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | — | IAS | — |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 0.475 | 0.66 | 0.012 | 0.216 | 196 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.255 | — | 0.002 | 0 | 190 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 0.73 | 0.66 | 0.059 | 0.318 | 1,821 |
Net Property, Plant And Equipment | — | — | 0.568 | 0.209 | 0.303 |
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 0.73 | 0.968 | 15.3 | 13.7 | 2,670 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.036 | 0.038 | 0.136 | 0.306 | 413 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 0.036 | 0.038 | 0.136 | 0.306 | 1,645 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 0.694 | 0.93 | 15.2 | 13.4 | 1,025 |
Total Liabilities & Shareholders' Equity | 0.73 | 0.968 | 15.3 | 13.7 | 2,670 |
Total Common Shares Outstanding |